In the second installment of our Alexion-sponsored series, Dr. Kathryn Dahir explores the complex genetics of HPP, why disease severity varies so widely, and the challenges of predicting symptoms.
All in In-Person
With 4 precision treatments now approved or in late-stage development, we explore how the expanding achondroplasia treatment landscape could shape growth, body proportionality, function, and family decision-making.